Cynosure Group’s Vicor VICR Stock Holding History

Cynosure Group’s Portfolio VICR Stock Details VICR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$856K	Sell	2,253 -121	-5%	-$33K	0.13%	49
2026 Q1	$382K	Buy	+2,374	New	+$392K	0.05%	160

Other funds holding VICR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Cynosure Group's VICR Position: Q2 2026 in Review

Cynosure Group reduced its Vicor (VICR) stake by 5.1% in Q2 2026, selling an estimated $33K and leaving 2,253 shares worth $856K. The position accounts for 0.13% of the portfolio, ranked #49.

Cynosure Group first reported a position in VICR in Q1 2026 and has held it in 2 quarters since. 515 funds tracked by Wall St. Rank hold VICR as of Q2 2026.

Cynosure Group held 2,253 shares of Vicor worth $856K as of Q2 2026.
Cynosure Group sold 121 Vicor shares in Q2 2026, an estimated $33K.
Vicor made up 0.13% of Cynosure Group's portfolio in Q2 2026, its #49 holding.
Cynosure Group first reported a position in Vicor in Q1 2026 and has held it in 2 quarters since.
515 funds tracked by Wall St. Rank held Vicor as of Q2 2026.

Based on Cynosure Group's 13F filing for Q2 2026, filed 5 Aug 2026.